German Machinery Stock News

DB:93M1
DB:93M1Pharmaceuticals

MPH Health Care (DB:93M1) EPS Loss Deepens Challenging Bullish Profitability Narratives

MPH Health Care (DB:93M1) has just reported its FY 2025 results with first half revenue of €5.5 million and a basic EPS loss of €17.00, setting a cautious tone around top line scale and per share profitability. Over the previous reporting periods, revenue shifted from €84.2 million in the first half of 2024 to a decline of €18.8 million in the second half of 2024. Basic EPS moved from a gain of €17.41 in early 2024 to a loss of €9.92 in late 2024 and then a deeper loss in the latest half,...
XTRA:DHER
XTRA:DHERHospitality

Uber’s Delivery Hero Offer Reshapes Deal Scenarios And Shareholder Outcomes

Uber has made an indicative cash offer to acquire Delivery Hero, which the company rejected. Reports suggest Uber is preparing a higher bid and has built a 19.5% stake in Delivery Hero. Delivery Hero's board is reviewing options that include a full sale or divestitures of core regions. Regulatory and antitrust scrutiny are emerging as key considerations for any potential transaction. Delivery Hero (XTRA:DHER) sits at the center of a fast evolving M&A story, with Uber moving from suitor to...
XTRA:SAP
XTRA:SAPSoftware

Is There Now An Opportunity In SAP (XTRA:SAP) After A Steep Share Price Decline?

If you are wondering whether SAP at €151.80 offers value or risk at this point in the cycle, this article breaks down what the current price might be implying about the stock. The share price is broadly flat in the near term, with SAP up 0.6% over the past week and 2.0% over the past month. However, the stock is still down 24.8% year to date and down 41.2% over the past year, which may change how you think about its risk and return trade off. These moves sit against a backdrop of ongoing...
XTRA:IVU
XTRA:IVUSoftware

IVU Traffic Technologies Q1 EPS Rebound Tests Growth Narrative For Premium P/E Multiple

IVU Traffic Technologies (XTRA:IVU) has opened 2026 with Q1 revenue of €35.0 million and basic EPS of €0.063, alongside trailing 12 month revenue of €155.2 million and EPS of €0.821 that frame the latest quarter in a broader earnings context. The company has seen quarterly revenue move from €30.8 million in Q1 2025 to €35.0 million in Q1 2026, while basic EPS moved from €0.009 to €0.063 over the same period. This sets up a results season where the key question is how durable these earnings...
XTRA:TPE
XTRA:TPESemiconductor

PVA TePla (XTRA:TPE) Margin Collapse To 0.8% Tests Bullish Growth Narratives

PVA TePla (XTRA:TPE) opened Q1 2026 with revenue of €54.9 million and a basic EPS loss of €0.10, as net income excluding extra items came in at a loss of €2.1 million. Over recent quarters the company has seen revenue move between €58.8 million and €71.8 million with basic EPS ranging from a €0.001 loss to €0.42. On a trailing 12-month view, this translates to revenue of €240.3 million and basic EPS of €0.10, setting up a picture where growth expectations are running against currently...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Should Kerendia Priority Review in Type 1 Kidney Disease Require Action From Bayer (XTRA:BAYN) Investors?

Earlier this month, Bayer announced that the U.S. FDA accepted a supplemental New Drug Application and granted Priority Review for Kerendia (finerenone) in adults with type 1 diabetes and chronic kidney disease, supported by Phase III FINE-ONE data showing significant reduction in urine albumin-to-creatinine ratio over six months alongside standard care. This move could broaden Kerendia’s use beyond its existing approvals in chronic kidney disease linked to type 2 diabetes and heart failure...
DB:8W50
DB:8W50Software

European Market Insights: Vidhance Leads 2 Noteworthy Penny Stocks

The European market has recently experienced a positive shift, with the pan-European STOXX Europe 600 Index rising by 3.00% amid hopes for de-escalation in the Middle East. This backdrop of cautious optimism sets an intriguing stage for investors considering penny stocks, which, despite their somewhat outdated label, continue to offer compelling opportunities within smaller or newer companies. With solid financial foundations and strategic positioning, these stocks can present...
XTRA:VRV
XTRA:VRVMedia

Verve Group Q1 Loss Revives Bearish Narrative On Fragile Profitability

Verve Group (XTRA:VRV) opened 2026 with Q1 revenue of €146.0 million and a basic EPS loss of €0.01, as net income excluding extra items came in at a loss of €2.9 million. Over recent quarters, revenue has moved between €111.1 million and €208.2 million while basic EPS has ranged from a loss of €0.02 to a profit of €0.08. This highlights how quickly earnings can swing as margins shift. With revenue now at the higher end of its recent range but EPS back in loss making territory, the focus for...
XTRA:AG1
XTRA:AG1Specialty Retail

AUTO1 Group (XTRA:AG1): Do Profits, Cash Burn And Goldman’s Stake Align Into A Coherent Story?

AUTO1 Group SE recently reported profit growth but also disclosed a very large €487,000,000 cash burn over the last year, prompting analyst concerns about the lack of free cash flow and the quality of its earnings. At the same time, Goldman Sachs revealed it now controls about 9.20% of AUTO1 Group’s voting rights through shares and instruments, underscoring growing institutional attention just as questions emerge about how resilient those reported profits really are. We’ll now examine how...
XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care (XTRA:FME) Valuation Check After A Year Of Weak Share Performance

Fresenius Medical Care: recent share performance in focus Fresenius Medical Care (XTRA:FME) has come back onto investor radars after a period of weaker share performance, with the stock down 7.1% year to date and 25.6% over the past year. See our latest analysis for Fresenius Medical Care. The recent drift in momentum, with a 30 day share price return of 3.94% and a 1 year total shareholder return decline of 25.61%, suggests sentiment has cooled after earlier gains over three years. If the...
XTRA:DTG
XTRA:DTGMachinery

A Look At Daimler Truck Holding (XTRA:DTG) Valuation After Mixed Short And Long Term Share Returns

Daimler Truck Holding stock reacts to recent performance data Daimler Truck Holding (XTRA:DTG) has come into focus after fresh performance data highlighted a mixed return profile, with the stock up over the past year but down over the past month and past 3 months. See our latest analysis for Daimler Truck Holding. At a share price of €41.68, Daimler Truck Holding shows a 7 day share price return of 6.57% but is down 5.27% over 30 days, while the 1 year total shareholder return of 15.45% and 3...
XTRA:VOW3
XTRA:VOW3Auto

Volkswagen (XTRA:VOW3) Valuation Check As Recent Trading Sends Mixed Share Price Signals

Volkswagen (XTRA:VOW3) stock continues to draw attention after recent trading, with the shares last closing at €90.50. Investors are weighing this price against the company’s earnings profile and multi-brand global footprint. See our latest analysis for Volkswagen. Recent trading has been mixed, with a 7 day share price return of 3.29% but a year to date share price return down 14.98%, while the 1 year total shareholder return has declined 5.18%. This suggests that momentum has softened...
XTRA:MBG
XTRA:MBGAuto

Is Mercedes-Benz Group (XTRA:MBG) Offering Value After A Mixed Year Of Share Price Moves

If you are wondering whether Mercedes-Benz Group is attractively priced or not, the stock offers plenty of data points to test what you are really paying for. The share price recently closed at €50.92, with returns of 2.8% over the past 7 days, 2.3% over the past 30 days, a decline of 17.8% year to date, and a 5.6% gain over the past year. Together, these figures present a mixed picture of sentiment. Recent coverage around Mercedes-Benz Group has focused on its position in the Auto industry...
XTRA:SIE
XTRA:SIEIndustrials

Is Siemens (XTRA:SIE) Still Attractive After Strong Multi‑Year Share Price Gains?

Wondering whether Siemens at €272.55 is offering good value or asking too much for its growth story is exactly the question this article will help you tackle. The stock has recorded returns of 6.1% over the last week, 12.1% over the last month, 13.0% year to date and 25.9% over the last year, with longer term returns of 87.0% over three years and 129.6% over five years. These moves sit against a backdrop of ongoing coverage of Siemens as a major European industrial and technology player,...
XTRA:LEG
XTRA:LEGReal Estate

Evaluating LEG Immobilien (XTRA:LEG) As Ex Dividend Date Nears And Dividend Sustainability Draws Focus

LEG Immobilien (XTRA:LEG) is in focus as its stock approaches the May 28 ex-dividend date, drawing attention from income investors who are weighing the appeal of its relatively low payout against recent earnings trends. See our latest analysis for LEG Immobilien. Recent trading suggests interest has picked up ahead of the ex-dividend date. The stock has posted a 2.9% 7-day share price return, yet the 1-year total shareholder return is down 18.2%. This hints that recent momentum contrasts with...
XTRA:BSL
XTRA:BSLElectronic

Is It Too Late To Consider Basler (XTRA:BSL) After Its 219% One Year Surge?

If you are wondering whether Basler at €28.60 still offers value after its recent run, this article walks through the numbers so you can judge the price for yourself. The stock has posted returns of 18.9% over the past week, 61.4% over the past month, 88.2% year to date and 218.8% over the past year. These changes can influence how investors view both its potential and its risks. Recent coverage has focused on Basler's share price performance and how investors are reacting to its position in...
XTRA:DHER
XTRA:DHERHospitality

Is It Too Late To Consider Delivery Hero (XTRA:DHER) After The Recent Share Price Surge?

Investors may be wondering whether Delivery Hero at €37.60 is still offering value after its recent run, or if most of the opportunity is already priced in. The stock has returned 20.7% over the past week, 92.8% over the past month, 64.8% year to date and 51.4% over the past year, while the 5-year return shows a decline of 66.6%. These moves have come alongside ongoing attention on Delivery Hero's position in food delivery and related services, as investors reassess how the business model...
XTRA:LHA
XTRA:LHAAirlines

New Lufthansa Supervisory Chair Puts Governance And Capital Choices In Focus

Deutsche Lufthansa (XTRA:LHA) has appointed Dr. Johannes Teyssen as chair of its supervisory board. The appointment brings in leadership experience from his prior executive roles, including at BP. This change marks a fresh corporate governance development for the airline group. For investors watching XTRA:LHA, the change at the top of the supervisory board comes as the stock trades around €8.172. Over the past month, the share price is up 12.7%, while the past year shows a 27.1% gain and a...
XTRA:SIE
XTRA:SIEIndustrials

A Look At Siemens (XTRA:SIE) Valuation As Guidance Reaffirmation Meets AI And IoT Growth Trends

Siemens guidance confirmation and sector trends put stock in focus Siemens (XTRA:SIE) is back on investor radars after reaffirming its fiscal 2026 earnings guidance toward the upper half of its 6% to 8% group revenue growth range, alongside fresh half year results. See our latest analysis for Siemens. The reaffirmed 2026 guidance and recent half year earnings have coincided with a firm upswing in sentiment, with a 13.49% 1 month share price return and a 136.66% 5 year total shareholder return...
XTRA:AIXA
XTRA:AIXASemiconductor

Assessing AIXTRON (XTRA:AIXA) Valuation After AI Infrastructure Enthusiasm And Strong Share Price Momentum

What sparked the latest move in AIXTRON? Recent enthusiasm for semiconductor equipment providers linked to global AI infrastructure build out has put AIXTRON (XTRA:AIXA) in focus. Investors are weighing its cash generation, zero debt position, and comparatively high P/E of 99. See our latest analysis for AIXTRON. That backdrop of AI infrastructure spending has coincided with strong momentum in AIXTRON’s stock, with a 30-day share price return of 15.95% and a 1-year total shareholder return of...